Atara Biotherapeutics, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | M | 0.00 | 1,603 | 0 | 13,354 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Buy | M | 0.00 | 1,603 | 0 | 12,286 | 10.7 K to 12.3 K (+15.01 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 7,083 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,548 | 0 | 12,388 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 16.30 | 1,183 | 19,283 | 94,280 | 95.5 K to 94.3 K (-1.24 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 95,463 | 94.6 K to 95.5 K (+0.86 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,548 | 0 | 94,646 | 93.1 K to 94.6 K (+1.66 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 4,146 | 0 | 31,784 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Option Exercise | M | 0.00 | 9,615 | 0 | 44,872 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 17.13 | 3,783 | 64,803 | 128,510 | 132.3 K to 128.5 K (-2.86 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Sell | S | 16.07 | 1,928 | 30,983 | 132,293 | 134.2 K to 132.3 K (-1.44 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 4,146 | 0 | 134,221 | 130.1 K to 134.2 K (+3.19 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Buy | M | 0.00 | 9,615 | 0 | 130,075 | 120.5 K to 130.1 K (+7.98 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 829 | 0 | 6,357 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Sell | S | 15.43 | 3,208 | 49,499 | 295,240 | 298.4 K to 295.2 K (-1.07 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 829 | 0 | 298,448 | 297.6 K to 298.4 K (+0.28 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | Chief R & QA Office ... | Option Exercise | M | 0.00 | 7,211 | 0 | 62,500 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | Chief R & QA Office ... | Sell | S | 15.35 | 4,153 | 63,749 | 80,700 | 84.9 K to 80.7 K (-4.89 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | Chief R & QA Office ... | Buy | M | 0.00 | 7,211 | 0 | 84,853 | 77.6 K to 84.9 K (+9.29 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 45,292 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 217,321 | 211.4 K to 217.3 K (+2.79 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,697 | 0 | 59,014 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,804 | 0 | 12,153 | |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Sell | S | 15.49 | 6,000 | 92,940 | 83,714 | 89.7 K to 83.7 K (-6.69 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 7,697 | 0 | 89,714 | 82 K to 89.7 K (+9.38 %) |
| Feb 18 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,804 | 0 | 82,017 | 79.2 K to 82 K (+3.54 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Haqq Christopher | Chief Medical Offic ... | Grant | A | 0.00 | 55,900 | 0 | 297,619 | 241.7 K to 297.6 K (+23.13 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | Chief R & QA Office ... | Grant | A | 0.00 | 42,857 | 0 | 77,642 | 34.8 K to 77.6 K (+123.21 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Turner Heather D | VP, General Counsel ... | Grant | A | 0.00 | 48,857 | 0 | 48,857 | 0 to 48.9 K |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Soffer Gad | Chief Operating Off ... | Grant | A | 0.00 | 48,447 | 0 | 120,460 | 72 K to 120.5 K (+67.28 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | Chief Financial Off ... | Grant | A | 0.00 | 42,857 | 0 | 79,213 | 36.4 K to 79.2 K (+117.88 %) |
| Feb 11 2016 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Grant | A | 0.00 | 163,973 | 0 | 211,413 | 47.4 K to 211.4 K (+345.64 %) |